[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@polycle Chocopie

Chocopie posts on X about $incy, acquisition the most. They currently have XXX followers and XXX posts still getting attention that total XX engagements in the last XX hours.

Engagements: XX #

• X Week XXX -XX%
• X Month XXXXXX -XX%
• X Months XXXXXXXXX +9.30%
• X Year XXXXXXXXX +27%

Mentions: X #

• X Week X -XX%
• X Month XXX +392%
• X Months XXX +2,183%
• X Year XXX +1,613%

Followers: XXX #

• X Week XXX +0.53%
• X Month XXX +2.50%
• X Year XXX -XXXX%

CreatorRank: undefined #

Social Influence

Social category influence stocks finance

Social topic influence $incy, acquisition

Top assets mentioned Incyte Corporation (INCY)

Top Social Posts

Top posts by engagements in the last XX hours

"@BioValues $INCY have no alternative. Merus has an acquisition-rights end for GenMab MacroGenics has recently stopped developing vobramitamab duocarmazine (B7-H3 ADC) and Escient Pharmaceuticals has also been toxic six months after the acquisition"
X Link 2025-12-12T02:33Z XXX followers, XX engagements